Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02960100 · ClinicalTrials.gov registry record · NA

mHealth Intervention in Increasing HPV Vaccinations in College Students

A NA study, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
101
Enrollment target

NCT02960100 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 101 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02960100, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
101 participants
Enrollment target

Study Summary

This randomized pilot trial studies how well a mobile health (mHealth) intervention works in increasing human papillomavirus (HPV) vaccination among college students at the Ohio State University. mHealth educational intervention may communicate information about HPV vaccination and increase HPV vaccine uptake in college students.

Interventions

  • OTHER Survey Administration
  • OTHER Media Intervention
  • OTHER Informational Intervention

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2016-10-18
Est. Completion 2017-08-31
Phase NA

What the Registry Record Tells You About NCT02960100

The ClinicalTrials.gov registry entry for NCT02960100 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Survey Administration is the first listed.

NCT02960100 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02960100 about?

NCT02960100 is a clinical study titled "mHealth Intervention in Increasing HPV Vaccinations in College Students". This randomized pilot trial studies how well a mobile health (mHealth) intervention works in increasing human papillomavirus (HPV) vaccination among college students at the Ohio State University. mHealth educational intervention may communicate information about HPV vaccination and increase HPV vacc...

What is the current status of trial NCT02960100?

This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2016-10-18. Estimated completion is 2017-08-31.

What interventions are being tested in trial NCT02960100?

The interventions under investigation include: Survey Administration (OTHER), Media Intervention (OTHER), Informational Intervention (OTHER).

Who is sponsoring clinical trial NCT02960100?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.